Fred Alger Management, LLC Fulcrum Therapeutics, Inc. Transaction History

Fred Alger Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$4.2 - $24.0 $205,468 - $1.17 Million	-48,921 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$9.96 - $23.65 $487,253 - $1.16 Million	48,921 New	48,921 $1.16 Million
Q2 2020 Aug 14, 2020	SELL	$9.11 - $22.06 $148,319 - $359,158	-16,281 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$9.49 - $21.26 $298,935 - $669,690	-31,500 Reduced 65.93%	16,281 $194,000
Q4 2019 Feb 14, 2020	SELL	$4.46 - $18.14 $264,732 - $1.08 Million	-59,357 Reduced 55.4%	47,781 $795,000
Q3 2019 Nov 14, 2019	BUY	$6.64 - $14.89 $711,396 - $1.6 Million	107,138 New	107,138 $711,000

150

52.2M

6.91M

1.9M

Ticker FULC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,038,900
Market Cap $156M
Description
Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...

Get notified when there are updates to the investment portfolio of Fred Alger Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Fred Alger Management, LLC with notifications on news.